Grade ≥3 or intolerable Grade 2:
Adapted from CTCAE version 3.5
CTCAE=common terminology criteria for adverse events
You're now leaving our website...
Click here for international product information intended for Healthcare Professionals about afatinib for non-small-cell lung cancer treatment.
Click here for general international information about afatinib for non-small-cell lung cancer treatment.